Skip to main content
SBFM
NASDAQ Life Sciences

Sunshine Biopharma Registers 25.5M Warrant Shares, Flags Nasdaq Delisting Risk

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.11
Mkt Cap
$4.459M
52W Low
$1.01
52W High
$24.3
52W Position info
9.9% above low
Off High info
95% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

SBFM is trading near its 52-week low of $1.01 (9.9% above the low).

Summary

Sunshine Biopharma registered 25.5 million warrant shares for potential exercise at $1.2202, while disclosing it fails Nasdaq's proposed $5 million market value requirement and faces immediate delisting risk until June 2027.


Key Events · Financing and Capital Events · SBFM

  • Warrant Share Registration

    Registered 25,477,133 shares underlying Series B Warrants at exercise price $1.2202, with maximum aggregate offering price of $31,087,198 if all warrants are exercised for cash.

  • Nasdaq Delisting Risk

    Company does not currently meet Nasdaq's proposed $5 million Market Value of Listed Securities requirement and is subject to immediate delisting notice until June 2027 if it fails the $1.00 bid price rule for 30 consecutive business days.

  • Warrant Overhang

    As of the prospectus date, the company has 29,512,762 outstanding warrants subject to adjustment, creating significant potential future dilution.

  • Use of Proceeds

    If all Series B Warrants are exercised for cash, net proceeds would be approximately $31 million, intended for general corporate purposes including working capital.


Analysis · SBFM · Life Sciences

Sunshine Biopharma filed an S-1 to register 25,477,133 shares underlying its Series B Warrants at an exercise price of $1.2202, potentially raising up to $31.1 million if all warrants are exercised for cash. The filing also discloses that the company does not currently meet Nasdaq's proposed $5 million market value requirement and remains subject to immediate delisting notice until June 2027 if it fails the $1.00 bid price rule. With a market cap of only $4.46 million, the company is already below the proposed threshold, making the delisting risk acute. The registration itself does not dilute shareholders unless warrants are exercised, but the disclosure of listing non-compliance is a material governance red flag that could force a delisting and severely impair liquidity and capital-raising ability.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.3% of the 1982 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SBFM was trading at $1.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $1.01 to $24.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SBFM - Latest Insights

SBFM
Nov 12, 2026, 11:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $2.70 info
Change: $0 (0%) info
Market Cap: $2.224M info
SBFM
Nov 12, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.81
Real-time Price: $2.70 info
Change: -$0.110 (-4%) info
Market Cap: $2.224M info
SBFM
Nov 12, 2026, 4:05 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.80
Real-time Price: $2.70 info
Change: -$0.100 (-4%) info
Market Cap: $2.224M info
SBFM
Oct 22, 2026, 9:25 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1638
Real-time Price: $2.70 info
Change: Reverse Stock Split info
Market Cap: $2.224M info
SBFM
Oct 14, 2026, 5:21 PM EDT
Filing Type: PRE 14C
Importance Score:
8
Price at Filing: $0.232
Real-time Price: $2.70 info
Change: Reverse Stock Split info
Market Cap: $2.224M info